Transaction Details

Footnotes

Represents restricted stock units ("RSUs") issued to the Reporting Person's spouse under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest 6.25% on each quarterly vesting date over four years, beginning on December 15, 2022. The transaction was not previously reported due to administrative oversight. Forms 4 filed after the transaction date understated the total common stock holdings of the Reporting Person's spouse by 1,392 shares. | The total in Column 5 has been adjusted to correct (i) an overstatement of holdings by 116 shares first reflected in a Form 4 filed on September 14, 2022 and (ii) an overstatement of holdings by 236 shares first reflected in a Form 4 filed on April 12, 2023. | Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. The transaction was not previously reported due to administrative oversight. Forms 4 filed after the transaction date overstated the total common stock holdings of the Reporting Person's spouse by 22 shares. | These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of RSUs. The transaction was originally reported in a Form 4 filed on December 20, 2023 that contained an error in the number of shares in Column 4. The transaction is being re-reported in order to correct the number of shares in Column 4. Forms 4 filed after the transaction date understated the total common stock holdings of the Reporting Person's spouse by 134 shares. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.